Tagged with HE

Mexico As the country’s most important patient organization for cancer, the Mexican Association for the Fight Against Cancer (AMLCC) focuses on education, prevention and patient support, as well as on influencing public affairs. CEO and long-term patient advocate Mayra Galindo walks us through some of the AMLCC’s milestones, including the creation…

Hong Kong Roche has a strong presence in Hong Kong with a local footprint dating back to 1971. Diana Liu, general manager of the Swiss pharma’s Hong Kong & Macau affiliate, outlines its growing local clinical research commitment, one that has seen its clinical trial activities increase 2.5 times and reach an…

Global 35 years after the specific mechanisms and structure of the human immunodeficiency virus were first identified, the world is still waiting for a vaccine against HIV. Several late-stage candidates have failed in this time, leading to most of the major pharma companies exiting HIV vaccine research. Some new early-stage approaches…

Saudi Arabia SEHA Virtual Hospital, the world’s largest such network, brings together 170 hospitals and around 600 primary healthcare centers in Saudi Arabia. As the organisation’s CEO Eng. Mona Sahman Al-Subaie explains, SEHA provides a wide range of virtual medical services from critical care to specialised clinics, aimed at increasing the accessibility…

Saudi Arabia As life expectancy increases, how do we ensure that quality of life does too? That is the conundrum that Saudi Arabia’s Hevolution Foundation was set up to help solve. Hevolution invests in extending the healthy human lifespan across the world through research and treatments which target age-related diseases and conditions.…

Global Brendan Shaw paints a concerning picture of global health priorities post-pandemic, highlighting the need for renewed focus and investment in healthcare systems to prevent further backsliding.   “There isn’t a financing gap. There is just money that is not moving towards the right things. There’s plenty of money out there”…

Saudi Arabia As Managing Director for Healthcare at Accenture Middle East, Samar Nassar oversees the global consultancy’s healthcare practice in the region, focusing on end-to-end management of large clients in both public and private sectors. Nassar highlights some of the key healthcare trends and challenges in the region, including workforce shortages, mental…

Saudi Arabia Mostafa Nagib outlines Lundbeck’s strategy and growth in Saudi Arabia, emphasizing their dedication to neuroscience and expanded access to innovative treatments. He discusses the challenges in mental health awareness and stigma as well as the journey of transforming Lundbeck Saudi to adapt to the Kingdom’s rapid development, fostering an environment…

Global Writing in the June 2024 edition of ISPOR’s Value in Health journal, Nancy J. Devlin, PhD, Michael F. Drummond, MCom, DPhil, and C. Daniel Mullins, PhD look back on the history of QALYs in cost-effectiveness analysis and policy decision making, and why the backlash against QALYs in the United States…

Hong Kong Industry veteran Krish Sundaresan, GM for Hong Kong & Macau at Pfizer for the past two and a half years, shares his experience navigating the shifting dynamics brought on by the COVID-19 pandemic, enhancing omni-channel capabilities, and launching four new products in 2023 alone. Sundaresen also discusses the opportunity to…

Saudi Arabia Over the past three years, Sanofi has significantly expanded its presence in the GCC region, launching 40-50 new products, including treatments for rare diseases and advancements in immunology, diabetes management, and vaccines. As Jean-Paul Scheuer explains, this expansion aligns with Sanofi’s goal to become a leading immunology company globally and…

Germany A roundup of some of the biggest stories coming out of German pharma, including Merck’s better-than-expected Q1 earnings; Stada’s possible return to the stock market; CDMO Vetter’s expanded capacity in the US and Germany; Bayer’s elimination of some 1,500 jobs, and BioNTech’s bid for MediLink’s solid tumour platform.   Merck…